Anders Ullman - Net Worth and Insider Trading

Anders Ullman Net Worth

The estimated net worth of Anders Ullman is at least $13 Million dollars as of 2024-11-12. Anders Ullman is the Director of Verona Pharma PLC and owns about 334,856 shares of Verona Pharma PLC (VRNA) stock worth over $13 Million. Details can be seen in Anders Ullman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anders Ullman has not made any transactions after 2021-05-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anders Ullman

To

Anders Ullman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anders Ullman owns 1 companies in total, including Verona Pharma PLC (VRNA) .

Click here to see the complete history of Anders Ullman’s form 4 insider trades.

Insider Ownership Summary of Anders Ullman

Ticker Comapny Transaction Date Type of Owner
VRNA Verona Pharma PLC 2021-05-04 director

Anders Ullman Latest Holdings Summary

Anders Ullman currently owns a total of 1 stock. Anders Ullman owns 334,856 shares of Verona Pharma PLC (VRNA) as of May 4, 2021, with a value of $13 Million.

Latest Holdings of Anders Ullman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRNA Verona Pharma PLC 2021-05-04 334,856 39.86 13,347,360

Holding Weightings of Anders Ullman


Anders Ullman Form 4 Trading Tracker

According to the SEC Form 4 filings, Anders Ullman has made a total of 2 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Verona Pharma PLC is the sale of 12,056 shares on May 4, 2021, which brought Anders Ullman around $10,127.

Insider Trading History of Anders Ullman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anders Ullman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anders Ullman Ownership Network

Ownership Network List of Anders Ullman

No Data

Ownership Network Relation of Anders Ullman

Insider Network Chart

Anders Ullman Owned Company Details

What does Verona Pharma PLC do?

Who are the key executives at Verona Pharma PLC?

Anders Ullman is the director of Verona Pharma PLC. Other key executives at Verona Pharma PLC include Chief Financial Officer Mark W Hahn , director & President and CEO David Zaccardelli , and Chief Medical Officer Kathleen A. Rickard .

Verona Pharma PLC (VRNA) Insider Trades Summary

Over the past 18 months, Anders Ullman made no insider transaction in Verona Pharma PLC (VRNA). Other recent insider transactions involving Verona Pharma PLC (VRNA) include a net sale of 2,255,536 shares made by David Zaccardelli , a net sale of 2,255,536 shares made by Mark W Hahn , and a net sale of 244,856 shares made by Kathleen A. Rickard .

In summary, during the past 3 months, insiders sold 3,600,000 shares of Verona Pharma PLC (VRNA) in total and bought 81,240 shares, with a net sale of 3,518,760 shares. During the past 18 months, 5,801,778 shares of Verona Pharma PLC (VRNA) were sold and 310,976 shares were bought by its insiders, resulting in a net sale of 5,490,802 shares.

Verona Pharma PLC (VRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verona Pharma PLC Insider Transactions

No Available Data

Anders Ullman Mailing Address

Above is the net worth, insider trading, and ownership report for Anders Ullman. You might contact Anders Ullman via mailing address: C/o Verona Pharma Plc, 3 More London Riverside, London X0 Se1 2re.